JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque Psoriasis
Percentage of patients with PASI-75 response was higher with the interleukin-23-receptor antagonist peptide
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.